Dr. Bradford Stephen Chervin, MD

Dr. Chervin practices at Sasco Hill Surgery Center - Southport in Southport, Connecticut.

Dr. Chervin's NPI, 1033215256, was assigned on September 15, 2006. Dr. Chervin graduated from George Washington University School of Medicine and Health Sciences in 1993. Dr. Chervin holds Connecticut license 037587.

Dr. Chervin's primary practice is Sasco Hill Surgery Center - Southport, at 2600 Post Road, Southport, CT 06890. The practice phone is (203) 763-1446.

Dr. Chervin's primary practice is Sasco Hill Surgery Center - Southport in Southport, Connecticut. Dr. Chervin is also affiliated with Cape Cod Hospital. The medical group on file is Medical Affiliates of Cape Cod (MACC). Dmand AI also links Dr. Chervin to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chervin practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Chervin's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Chervin is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Chervin's licenses on file in 3 states: Connecticut, Massachusetts and Tennessee.

Dmand AI lists acute sinusitis, chronic nasal allergies, ear eustachian tube disorders, ear infection, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear and tinnitus among the conditions Dr. Chervin treats.

CMS data shows 988 Medicare services from Dr. Chervin across 5 procedure codes in 2024, for 585 Medicare patients. Medicare paid $63,963 for them. Every service was in an office.

CMS counts 585 Medicare patients who saw Dr. Chervin in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chervin's median patient age at 62, with 53% women.

In 2024, Dr. Chervin wrote 184 Medicare Part D claims for 75 patients. 88% of them were for generic drugs. CMS names the drug for 118 of them, across 6 drugs with 11 or more claims each, at $47,498 in total drug cost. In 2023, CMS named 71 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Chervin for performance year 2024, reported individually. Dr. Chervin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 103 general payments to Dr. Chervin from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $699.

Dmand AI lists 3 awards for Dr. Chervin, most recently Top Doctors: New York Metro Area in 2016.

Dr. Chervin graduated from George Washington University School of Medicine and Health Sciences in 1993. Dr. Chervin is a member of NHS.

Dr. Chervin is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.